Catholic University of Louvain:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Catholic University of Louvain - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9323
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Catholic University of Louvain (UCL) is an educational service provider that offers undergraduate, post graduate and certificate programs. The university offers educational programs in the areas of science, agricultural sciences and biological engineering, motor sciences, dental sciences, engineering sciences, biomedical and pharmaceutical sciences, town planning, medical sciences, and veterinary science, among others. It offers research and technology transfer services. UCL also offers archaeology, operational research and econometrics, and statistics courses. The university operates through its campuses located in Louvain-la-Neuve, Mons, Brussels, Tournai and Charleroi. UCL is headquartered in Louvain-la-Neuve, Belgium.

Catholic University of Louvain – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Catholic University of Louvain, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Catholic University of Louvain, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Catholic University of Louvain, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Catholic University of Louvain, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Catholic University of Louvain, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Catholic University of Louvain, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Valbiotis Enters into Agreement with Catholic University of Louvain 10
arGEN-X Enters into Agreement with Catholic University of Louvain 11
Equity Offering 12
A-Mansia Biotech Spin Out from Wageningen University and Catholic University of Louvain 12
Catholic University of Louvain – Key Competitors 13
Catholic University of Louvain – Key Employees 14
Catholic University of Louvain – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Government and Public Interest 16
Dec 13, 2017: Scientists develop new artificial ovary prototype 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Catholic University of Louvain, Pharmaceuticals & Healthcare, Key Facts 2
Catholic University of Louvain, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Catholic University of Louvain, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Catholic University of Louvain, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Catholic University of Louvain, Deals By Therapy Area, 2012 to YTD 2018 8
Catholic University of Louvain, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Valbiotis Enters into Agreement with Catholic University of Louvain 10
arGEN-X Enters into Agreement with Catholic University of Louvain 11
A-Mansia Biotech Spin Out from Wageningen University and Catholic University of Louvain 12
Catholic University of Louvain, Key Competitors 13
Catholic University of Louvain, Key Employees 14
Catholic University of Louvain, Subsidiaries 15

List of Figures
Catholic University of Louvain, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Catholic University of Louvain, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Catholic University of Louvain, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Catholic University of Louvain, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Catholic University of Louvain, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Catholic University of Louvain, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Catholic University of Louvain, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Catholic University of Louvain, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Catholic University of Louvain:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BNC Bancorp:企業のM&A・事業提携・投資動向
    BNC Bancorp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BNC Bancorp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Agile Therapeutics Inc (AGRX):医療機器:M&Aディール及び事業提携情報
    Summary Agile Therapeutics Inc (Agile) is a healthcare company that develops and commercializes prescription contraceptive products for women. The company provides contraceptive patch containing the active ingredients levonorgestrel and ethinyl estradiol and progestin-only birth control patch. Its p …
  • Nacional Financiera S.N.C.:企業の戦略・SWOT・財務情報
    Nacional Financiera S.N.C. - Strategy, SWOT and Corporate Finance Report Summary Nacional Financiera S.N.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • GAIL (India) Ltd (GAIL)-エネルギー分野:企業M&A・提携分析
    Summary GAIL (India) Ltd (GAIL) is a vertically integrated gas company that carries out exploration and production, transmission of natural gas. It also has presence in petrochemical, liquid hydrocarbons and power and renewable sectors. GAIL is also a major LPG transmission company, besides managing …
  • Perrigo Company plc:企業の戦略・SWOT・財務分析
    Perrigo Company plc - Strategy, SWOT and Corporate Finance Report Summary Perrigo Company plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Alphabet Inc:企業の戦略・SWOT・財務情報
    Alphabet Inc - Strategy, SWOT and Corporate Finance Report Summary Alphabet Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Forrester Research, Inc.:企業の戦略・SWOT・財務分析
    Forrester Research, Inc. - Strategy, SWOT and Corporate Finance Report Summary Forrester Research, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • PT Bank CIMB Niaga Tbk (BNGA):企業の財務・戦略的SWOT分析
    PT Bank CIMB Niaga Tbk (BNGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Eckert & Ziegler BEBIG SA (EZBG):医療機器:M&Aディール及び事業提携情報
    Summary Eckert & Ziegler BEBIG SA (Eckert & Ziegler), a subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG is a medical device company that produces and distributes brachytherapy and radiotherapy products. The company offers products such as permanent prostate implants, HDR afterloaders, …
  • TransMed7 LLC:企業の製品パイプライン分析
    Summary TransMed7 LLC (TransMed7) is a medical technology company that develops and manufactures biopsy devices. The company offers handheld soft tissue biopsy, stereotactic soft tissue biopsy, fine needle biopsy, vascular intervention, excisional soft tissue biopsy, prostate soft tissue biopsy, end …
  • Cochin Shipyard Ltd (COCHINSHIP):企業の財務・戦略的SWOT分析
    Cochin Shipyard Ltd (COCHINSHIP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • EnergyAustralia Pty Ltd:電力:M&Aディール及び事業提携情報
    Summary EnergyAustralia Pty Ltd (EnergyAustralia), formerly TRUenergy, is an electric utility that invests in energy generation and retailing activities. The company generates electricity and retails power and gas. It produces electricity from coal, gas, solar and wind sources. EnergyAustralia offer …
  • Fujifilm SonoSite Inc:企業の戦略的SWOT分析
    Fujifilm SonoSite Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • OPKO Health Inc (OPK):製薬・医療:M&Aディール及び事業提携情報
    Summary OPKO Health Inc (OPKO) discovers, develops, manufactures and commercializes novel diagnostic technologies and pharmaceuticals. The company’s product portfolio includes point-of-care tests, laboratory developed tests (LDTs), molecular diagnostics tests, and proprietary pharmaceuticals and vac …
  • SaskEnergy Inc:企業の戦略的SWOT分析
    SaskEnergy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Stada Arzneimittel AG (SAZ)-医療機器分野:企業M&A・提携分析
    Summary Stada Arzneimittel AG (STADA) is a pharmaceutical company that manufacturers low-cost generics and branded over the counter products. The company develops and markets drugs with off-patent active pharmaceutical ingredients, particularly, which are free from commercial property rights. It off …
  • Continuus Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Continuus Pharmaceuticals Inc (Continuus) is a provider of integrated continuous manufacturing technology for small molecule pharmaceuticals. The company offers an integrated continuous manufacturing technology that produces finished drug tablets from raw chemical ingredients without interru …
  • Diagnostic Medical Systems SA (DGM):医療機器:M&Aディール及び事業提携情報
    Summary Diagnostic Medical Systems SA (DMS) is a medical device company that designs, manufactures and distributes imaging systems. The company’s products comprise radiography and fluoroscopy, retrofit kits, mammography, chest and bone rooms, mobiles, bone densitometry, 3D reconstruction, mobile C-a …
  • Omnicell Inc (OMCL):企業の財務・戦略的SWOT分析
    Omnicell Inc (OMCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • EndoChoice Inc:医療機器:M&Aディール及び事業提携情報
    Summary EndoChoice Inc (EndoChoice), a subsidiary of Boston Scientific Corp is a medical device company that develops and commercializes medical devices, diagnostic equipment, infection control products and endoscopic imaging systems. The company’s infection control products comprise biopsy valves, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆